← All companies
Hold Current rating · 2 reports
Hold Recap: Q2 2026
Guidance Up Six Points, Stock Down Six Percent: The Pill Works, US Wegovy Injectable Falls 22%
Hold Recap: Q1 2026
Wegovy Pill Sets a Launch Record, and Novo Still Under-Grew an 85% US Obesity Market
The depth and quality Wall Street pays for — free.
Missed the earnings call? Don't miss our breakdown.